These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 31456191)

  • 21. Epigenetic therapy--a new development in pharmacology.
    Peedicayil J
    Indian J Med Res; 2006 Jan; 123(1):17-24. PubMed ID: 16567863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HDACis (class I), cancer stem cell, and phytochemicals: Cancer therapy and prevention implications.
    Bayat S; Shekari Khaniani M; Choupani J; Alivand MR; Mansoori Derakhshan S
    Biomed Pharmacother; 2018 Jan; 97():1445-1453. PubMed ID: 29156535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer chemoprevention by dietary polyphenols: promising role for epigenetics.
    Link A; Balaguer F; Goel A
    Biochem Pharmacol; 2010 Dec; 80(12):1771-92. PubMed ID: 20599773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resveratrol up-regulates ATP2A3 gene expression in breast cancer cell lines through epigenetic mechanisms.
    Izquierdo-Torres E; Hernández-Oliveras A; Meneses-Morales I; Rodríguez G; Fuentes-García G; Zarain-Herzberg Á
    Int J Biochem Cell Biol; 2019 Aug; 113():37-47. PubMed ID: 31173924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review.
    Sahafnejad Z; Ramazi S; Allahverdi A
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic induction of tissue inhibitor of matrix metalloproteinase-3 by green tea polyphenols in breast cancer cells.
    Deb G; Thakur VS; Limaye AM; Gupta S
    Mol Carcinog; 2015 Jun; 54(6):485-99. PubMed ID: 24481780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic utility of epigenetics in breast cancer - A review.
    Bhat SA; Majid S; Wani HA; Rashid S
    Cancer Treat Res Commun; 2019; 19():100125. PubMed ID: 30802811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells.
    Khan MA; Hussain A; Sundaram MK; Alalami U; Gunasekera D; Ramesh L; Hamza A; Quraishi U
    Oncol Rep; 2015 Apr; 33(4):1976-84. PubMed ID: 25682960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic therapy for breast cancer.
    Cai FF; Kohler C; Zhang B; Wang MH; Chen WJ; Zhong XY
    Int J Mol Sci; 2011; 12(7):4465-87. PubMed ID: 21845090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics.
    Duan YT; Sangani CB; Liu W; Soni KV; Yao Y
    Curr Top Med Chem; 2019; 19(12):972-994. PubMed ID: 31161992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
    Valdespino-Gómez VM; Valdespino-Castillo VE
    Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic therapies in patients with solid tumors: Focus on monotherapy with deoxyribonucleic acid methyltransferase inhibitors and histone deacetylase inhibitors.
    Katarzyna R; Lucyna B
    J Cancer Res Ther; 2019; 15(5):961-970. PubMed ID: 31603095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective Epigenetic Actions of Organo-Sulfur Compounds against Cancer: Perspectives and Molecular Mechanisms.
    Shoaib S; Ansari MA; Ghazwani M; Hani U; Jamous YF; Alali Z; Wahab S; Ahmad W; Weir SA; Alomary MN; Yusuf N; Islam N
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of epigenetic drugs in sensitizing cancers to anticancer therapies: emerging trends and clinical advancements.
    Singh D; Khan MA; Siddique HR
    Epigenomics; 2023 Apr; 15(8):517-537. PubMed ID: 37313832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenomes as therapeutic targets.
    Hamm CA; Costa FF
    Pharmacol Ther; 2015 Jul; 151():72-86. PubMed ID: 25797698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression pattern of DNA-methyltransferases and its health implication (short review).
    Kvaratskhelia E; Tkemaladze T; Abzianidze E
    Georgian Med News; 2014 Mar; (228):76-81. PubMed ID: 24743128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Phytochemicals and Dietary Patterns on Epigenome and Cancer.
    Zam W; Khadour A
    Nutr Cancer; 2017; 69(2):184-200. PubMed ID: 28094554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progress and promises of epigenetic drugs and epigenetic diets in cancer prevention and therapy: A clinical update.
    Mondal P; Natesh J; Penta D; Meeran SM
    Semin Cancer Biol; 2022 Aug; 83():503-522. PubMed ID: 33309850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.